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Pain in the orofacial region is by far the commonest reason for patients to seek 
treatment. Tooth and intraoral structures are often the main sources of orofacial 
pain. Odontogenic pain, also commonly known as tooth pain, originates from dental 
structures, pulpal or periodontal. Nonodontogenic oral pain can originate from 
intraoral structures such as gingiva and buccal mucosa. Arriving at a correct and 
definitive diagnosis is of paramount importance to institute an appropriate treat-
ment. Obtaining a detailed history from the patient including the location, duration, 
frequency, periodicity, character, and quality of pain assists in differentiating odonto-
genic from nonodontogenic causes. Wide varieties of pharmacological agents, along 
with invasive and noninvasive procedures, are available to manage odontogenic and 
nonodontogenic pain. While managing orofacial pain, clinical and pharmacological 
judgment should encompass a systematic and objective assessment in compliance 
with the strongest evidence available. In this chapter, there will be a discussion of vari-
ous choices and options available to manage a few of the orofacial pain complaints.
Keywords: orofacial pain, odontogenic pain, nonodontogenic oral pain,  
pain management, pulpitis, periapical periodontitis, traumatic periodontitis,  
cracked tooth syndrome, noninfectious and nonmalignant oral ulcers,  
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1. Introduction
Odontogenic pain, a common malady globally and the most prevalent type of oro-
facial pain, originates from dental structures, pulpal or periodontal [1]. Differential 
diagnosis for odontogenic pain is outlined in Table 1. Oral pain of nonodontogenic 
origin can originate from the intraoral structures, such as buccal mucosa, gingival 
tissues, and alveolar bone. Some of the main causes for nonodontogenic pain of 
oral origin are shown in Table 2. The complexity of the orofacial region makes the 
management of odontogenic and nonodontogenic pain of oral origin a challenging 
task for the clinicians. For an effective diagnosis and treatment, the clinician should 
have a thorough knowledge of the various pain complaints pertaining to the orofacial 
region and the different options available for their optimal management [2, 3].
For managing odontogenic pain, The “3-D’s” principle—diagnosis, dental 
treatment, and drugs—should be used. The first and foremost step is to determine 
the condition causing the pain and then to discover that what caused that condi-
tion. Removal of the cause usually leads to rapid recovery and should be done by an 
appropriate dental treatment. Medications should only be used to complement the 
dental treatment [4].
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• Noninfectious and nonmalignant oral ulcers
• Acute pericoronitis
• Acute alveolar osteitis (dry socket)
• Burning mouth syndrome (BMS)
• Oral mucositis (OM)
• Acute necrotizing ulcerative gingivitis (ANUG)
• Desquamative gingivitis (DG)
Table 2. 
Causes of nonodontogenic pain of oral origin.
For managing nonodontogenic pain particularly in complex cases, a multi-
disciplinary pain management approach should be adopted encompassing both 




Dissolution of the dental enamel results in development of dental caries. If 
caries goes unchecked, it may involve the dentin and the pulp, resulting in pain. 
In the initial stages, caries penetrates and exposes the dentin leading to dentine 
hypersensitivity. The pain due to dentin exposure is of a sharp and shooting nature 
with a shorter duration and is classically stimulated by exposure to heat, cold, sweet 
drinks/food, and mechanical trauma such as tooth brushing. Apart from caries, 
there exist other predisposing factors for dentine hypersensitivity. These include 
anatomical defects, gingival recession, erosion, abrasion, and attrition. The diagno-
sis of dentine hypersensitivity is based upon detection of dentin exposure or tooth 
wear. Therapies for managing dentinal hypersensitivity are aimed at: sealing the 
exposed dentinal tubules (composite resin application), reducing dentinal neuron 
activity (application of desensitizing agents such as potassium nitrate and stron-
tium chloride), and making the enamel and dentin more resistant to demineraliza-
tion (application of fluoride-containing medicaments) [6, 7].
Origin Possible causes




Periodontal pain Periapical periodontitis
• Periapical abscess
• Periapical granuloma and cyst
Traumatic periodontitis
Periodontal (lateral) abscess
Perio-endo, endo-perio, and combined lesions
Table 1. 
Differential diagnosis for odontogenic pain.
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2.1.2 Reversible and irreversible pulpitis
The extension of caries to pulp leads to pulpal inflammation known as pulpitis. 
Other cause of pulpitis can be operative dental procedures. The chemicals, heat, 
and friction involved in such procedures may trigger pulpal inflammation. Pulpitis 
has two clinical forms: acute (reversible) and chronic (irreversible). Acute pulpitis 
represents mild inflammation and is characteristically associated with sharp and 
shooting pain of a shorter duration. On the other hand, inflammation in irreversible 
pulpitis is severe enough to undermine the pulp. It is characterized by spontane-
ous and dull pain that persists even after the removal of a stimulus such as cold or 
heat [6–8].
Diagnosis of pulpitis is based mainly on clinical evaluation and pulp vitality 
tests. Radiographs can be helpful in cases where carious lesions are not clinically 
visible [8, 9].
The management strategies are determined based on the type of pulpitis and 
presence of infection involving the periapical area. In reversible pulpitis, pulp vital-
ity can be maintained if the tooth is treated, usually by removing the caries, and 
then restored [10]. In irreversible pulpitis, management options include endodontic 
(root canal) therapy or tooth extraction. In root canal treatment, an opening is 
made in the tooth and the pulp is extirpated. The root canal system is thoroughly 
cleaned, shaped, and then obturated with gutta-percha points. Following root canal 
therapy, adequate healing is manifested clinically by resolution of symptoms and 
radiographically by bone filling in the radiolucent area at the root apex over a period 
of months. If symptoms persist or worsen, root canal therapy is usually repeated in 
case a root canal was missed [11, 12].
2.1.3 Cracked tooth or cracked cusp syndrome
Cracked tooth syndrome occurs when a crack has occurred in the enamel or den-
tine and reaches the pulp chamber. The crack is usually not visible to the naked eye. 
Application of excessive force on a normal tooth or physiologic forces applied to a 
weakened tooth can lead to cracks. The diagnosis of cracked tooth is often tricky. 
Radiography is not helpful in detection of fractures, as cracks occur in a mesiodistal 
direction, parallel to that of the plane of the film. Simple test is to have patient bite 
on a cotton roll that evokes a sharp pain. Pain due to cracked tooth is sharp and 
shooting in nature, and is usually associated with biting and chewing. Hot and cold 
stimuli also evoke the pain. Restorable teeth should be treated endodontically, fol-
lowed by a full-coverage restoration of tooth. However, tooth with large cracks may 
require extraction [7, 13].
2.2 Periodontal pain
2.2.1 Periapical periodontitis (periapical abscess, granuloma, and cyst)
Pulpitis, if untreated, is followed by death of the pulp. The necrotic pulp is 
infected and leads to spread of infection through the apical foramina into the periapi-
cal tissues. This in turn causes inflammation and destruction of the periradicular 
tissues known as periapical periodontitis. It includes acute/chronic nonsuppurative 
inflammation and suppurative inflammation. Periapical granuloma forms due to 
chronic inflammation without pus, while periapical abscess is the result of inflamma-
tion involving pus. The other likely cause of periapical periodontitis can be chemical 
irritation. This irritation can be due to the escape of antiseptics used for root canal 
sterilization through the root apex into the surrounding periapical area [11, 12].
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Acute periapical abscesses characteristically present with severe pain in the area 
of the nonvital tooth particularly on percussion, inflammation, or complaint of pus 
drainage (with its associated foul taste). Pain also typically interferes with sleep. 
Treatment includes drainage through an opening in the tooth itself or through the 
soft tissue surrounding the jaw, if cellulitis has developed. If patients with abscess 
have systemic signs of infection (e.g., fever), an oral antimicrobial is prescribed 
(amoxicillin 500 mg every 8 hours; for patients allergic to penicillin, clindamycin 
150 or 300 mg every 6 hours). On resolution of the abscess, the patient should 
undergo root canal therapy or extraction [8, 10, 11, 14].
Periapical granulomas or cysts usually follow acute pulpal infection that remains 
unresolved due to inadequate drainage. Tooth with periapical granulomas may pres-
ent with a dull pain or may be asymptomatic. Radiographically, abscesses, granulo-
mas, or cysts have the same features and microscopic examination should be done 
for distinction. Teeth with periapical granulomas are nonvital and needs root canal 
treatment or removal. Root canal treatment done competently leads to healing even 
if cystic phase has started. Persistence of periapical radiolucency after 6–12 months 
may be due to technical faults associated with root canal treatment. In such a case, 
apical curettage with apicoectomy may be indicated [6, 8, 14, 15].
2.2.2 Traumatic periodontitis
Traumatic periodontitis is a painful condition that arises because of injury to the 
periodontium. This injury is caused by the trauma from excessive occlusal forces. 
The occlusal trauma affecting periodontium can be primary, secondary, or com-
bined. Tooth or teeth with normal periodontal support enduring increased occlusal 
loads may undergo primary occlusal trauma. The causes may include bruxism, over-
extended margins of restorations, excessive loading during orthodontic movements, 
and recent fitting of a new partial denture. Tooth or teeth with inadequate periodon-
tal support if subjected to normal occlusal forces may undergo secondary occlusal 
trauma. Excessive occlusal force on a diseased periodontium may lead to combined 
occlusal trauma. The excessive occlusal forces are generally from parafunctional 
movements such as bruxism. The clinical features of traumatic periodontitis include 
pain on chewing/biting or percussion, progressive tooth mobility, and nonphysi-
ological movement of tooth during function (fremitus). Additionally, there can be 
gingival inflammation with pocket formation in combined occlusal trauma.
Radiographic features include evidence of circumferential and furcal bone loss, 
in combination with widening of the periodontal ligament space.
The goal of management of traumatic periodontitis is the removal of excessive 
occlusal forces and brings the dentition in occlusal harmony. Primary occlusal trauma 
can be managed with analysis and correction of occlusion. One or more of the fol-
lowing steps can do occlusal adjustments: tooth movements, tooth removal, dental 
restorations, coronoplasty, etc. Progressive tooth mobility due to secondary occlusal 
trauma may be reduced by occlusal adjustment. Pain occurring due to hypermobility 
can be managed by splinting of teeth. The aim of splinting is to increase the resistance 
of dentition to the occlusal forces through stabilization. It involves joining of two or 
more teeth [16, 17]. Managing the periodontal inflammation is of primary impor-
tance in cases of combined occlusal trauma. Premature occlusal contacts usually 
contribute to the progression of periodontitis. This can be tackled by simple correc-
tion of the occlusion that may eradicate the premature occlusal contacts [16, 17].
2.2.3 Periodontal (lateral) abscess
A periodontal abscess arises because of acute infection of a periodontal pocket. 
Unlike a periapical abscess, periodontal abscess is associated with a vital tooth. 
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Varieties of reasons are implicated in causation of periodontal abscess. Primarily 
incomplete calculus removal can be a causative factor. Occasionally, it may occur 
following root planing, as the trauma to pocket lining implants bacteria into the 
periodontal tissues. Other contributing factors can be food packing down between 
teeth with poor contact points or foreign body (e.g., fish bone) driven through the 
floor of a pocket. Poorly controlled diabetes mellitus can also be a predisposing 
factor for periodontal abscess formation.
Periodontal abscess has a rapid onset. The gingival swelling and inflamma-
tory edema prevent drainage through the pocket orifice. The initial gingival 
tenderness progresses to throbbing pain that is well localized. The affected tooth 
is tender to percussion or biting. There is tooth mobility with its elevation in the 
socket. Pus exudation may occur from the pocket; however, a deep abscess has a 
sinus tract that points on the alveolar mucosa. Fever and regional lymphadenopa-
thy can be occasional clinical features. The vitality of the tooth, deep pocketing, 
and less severe tenderness helps to differentiate between a periodontal and 
pulpal abscess.
Periodontal abscess should be ideally drained through pocket or occasionally 
by an incision through the gingiva. If the abscess is too large and drainage cannot 
be done, subgingival scaling and root planing or deferring the surgical access until 
the major clinical signs have subsided. Before initiating the treatment of acute 
periodontal abscess, the evaluation of patient’s medical history, dental history, and 
systemic conditions is crucial to determine the need for antibiotics. The indications 
for antimicrobial therapy in patients with acute abscess are fever, lymphadenopa-
thy, evidence of spreading of infection (cellulitis), deep periodontal pocketing, and 
immunosuppression. Administration of antibiotics alone without the local drainage 
of the abscess is contraindicated. The drainage is mandatory in order to eliminate 
the etiologic factors. Extraction of the affected tooth can be considered as a last 
resort to treat the periodontal abscess, if there is poor response to therapy, horizon-
tal tooth mobility exceeding 1 mm, pocketing exceeding 8 mm, and more than 40% 
alveolar bone resorption [6, 18, 19].
2.2.4 Perio-endo, endo-perio, and combined lesions
In perio-endo lesions, microorganisms from the periodontal pockets can reach the 
pulp through accessory canals, thereby leading to pulpal inflammation and necrosis.
In endo-perio lesions, pulpal necrosis leads to involvement and destruction of 
the periodontal ligament and adjacent alveolar bone. Clinically endo-perio lesions 
present as deep periodontal probing depth extending to the apex of the tooth.
In managing the lesions of pulpal or periodontal origin, making an accurate 
diagnosis as to the source of infection is a critical determinant of the treatment 
outcome. Sequence of the disease process can be an important factor in determining 
the exact nature of lesions: perio-endo and endo-perio lesions. Conventional root 
canal therapy (RCT) alone leads to a complete resolution of the periodontal defects 
arising from primary pulpal infection. However, pulpal infections resulting from 
primary periodontal infections require both endodontic and periodontal treatments 
for achieving complete healing [18].
3. Nonodontogenic pain of oral origin
Oral ulcers are a broad entity that encompasses a variety of causes, such as infec-
tions (bacterial, viral, and fungal), neoplasia, immunological disturbances, drug 
reactions, etc.
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3.1 Noninfectious and nonmalignant oral ulcers
A detailed clinical history and examination, and laboratory investigations 
including biopsy, culture, and immunochemistry tests are essential for ruling 
out the neoplastic, infectious, and immunological causes of oral ulcerations. The 
causative factors for noninfectious and nonmalignant oral ulcers usually include 
mechanical trauma (self-induced trauma such as on chewing and biting, aggressive 
tooth brushing, and iatrogenic causes particularly due to dental treatment) and 
chemicals (aspirin, acetylsalicylic acid, acid etchants, etc.)
Superficial ulcers usually lead to soreness; severe pain and discomfort are the 
features of deep ulcers.
On elimination of cause, acute forms of traumatic- and chemical-induced 
ulcers usually heal in 7–10 days. They develop chronicity if subjected to continuous 
trauma or irritation. The considerations in management of such type of ulcers are 
as follows:
1. Maintenance of oral hygiene. In the presence of an ulcer, tooth brushing particu-
larly near to the ulcerative area can be detrimental. In such as case, an antiseptic 
mouthwash (e.g., 0.2% chlorhexidine solution) can be of considerable help. 
Chlorhexidine mouth rinse is recommended to be used three times daily after 
meals and held in the mouth for at least 1 minute. Oral rinsing with chlorhexidine 
has been found to lessen down the discomfort and duration of aphthous stomatitis.
2. Avoidance of irritation or injury to the area of ulceration. Covering agents, 
e.g., carboxymethylcellulose paste (Orabase®) and carmellose sodium can be 
helpful in safeguarding the ulcers from the effects of friction or injury. When 
correctly applied, these covering agents absorb moisture and form an adhesive 
gel, which can remain in place for several hours.
3. For management of pain, over-the-counter anesthetic agent (an example is 
Orobase® with 20% benzocaine). Topical application of weak potency corticos-
teroids (hydrocortisone hemisuccinate) and medium potency steroids (triamci-
nolone acetonide) also assist in reducing the associated pain and inflammation; 
however, they are unlikely to expedite the healing of ulcers. Hydrocortisone 
hemisuccinate 2.5 mg pellets allowed to be dissolved in the mouth close to ulcers, 
three times a day. Triamcinolone 0.1% in Orabase applied to ulcer three times 
daily. However, long-term and/or repeated topical application of such corticos-
teroids has a downside in the form of adrenal suppression. This concern can be 
addressed by using the topical corticosteroids at the lowest possible concentration 
and frequency. The problem of adrenal suppression is not evidenced with 0.05% 
fluocinonide in adhesive paste and betamethasone-17-valerate mouth rinse.
Tetracycline (e.g., doxycycline), or tetracycline plus nicotinamide in rinse 
form may provide significant pain relief and reduce ulcer duration, particularly 
in aphthous ulcers. However, usage of tetracycline should be avoided in children 
below 12 years of age due to the risk of tooth staining. For oral rinsing, a tetracycline 
capsule (250 mg) is crushed and stirred in a little water and held in the mouth for 
2–3 minutes, three times daily.
Tetracycline mouth rinses can also reduce the frequency of aphthous ulcers on 
regular usage for 3 days each week.
Salicylates based on their anti-inflammatory role can be helpful in reducing the 
discomfort of oral ulcers. Over the counter, preparation of choline salicylate in gel 
form is recommended for application to ulcers, 3–5 times daily [6, 20, 21].
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3.2 Acute pericoronitis
It is the inflammation of the flap of tissues (operculum) around an erupting 
tooth, and most commonly associated with impacted mandibular third molars. The 
chief complaints in this condition are severe pain that can radiate to surrounding 
areas and swelling of the pericoronal tissues. The hyperplastic-inflamed flap of 
tissue can become a hotbed for bacteria, as it readily holds food particles and debris. 
This scenario leads to bacterial infection with clinical manifestations of discharge 
of pus, trismus, fever, regional lymphadenopathy, and in some cases spread of the 
infection to adjacent tissue spaces.
If the pain and inflammation are limited to the tooth, local measures, such as 
debridement of food debris and plaque, irrigation with normal saline or hydrogen 
peroxide, and avoidance of occlusal trauma are recommended.
Antimicrobial therapy is indicated for patients presenting with fever, trismus, and 
pus exudation. Metronidazole 400 mg three times a day for 5 days is to be prescribed 
in combination with phenoxymethylpenicillin 500 mg four times a day for 5 days.
If it is envisaged that the tooth can be useful for chewing and patient also has 
the desire to retain the tooth, hyperplastic pericoronal tissue should be excised out 
through a minor oral surgery procedure known as operculectomy. This will allow 
better access to properly clean the area and prevent the accumulation of bacteria 
and food debris. In some unfortunate instances, the gum tissue may grow back and 
create the same problem.
Since impacted teeth frequently are unfavorably aligned and do not erupt com-
pletely, extraction of such tooth is commonly performed. This method eliminates 
any chance of recurrence of pericoronitis.
The risks and benefits of removal of impacted molars are mired in controversy, 
as extraction can lead to inferior alveolar nerve damage; retention can precipitate 
serious, even life-threatening infection [14, 22].
3.3 Acute alveolar osteitis (dry socket)
This painful condition is a complication that may occur following dental extrac-
tion. It presents with a severe throbbing pain caused by bone exposure at the site 
of extraction. Following the extraction, a blood clot forms within the extraction 
socket to safeguard the bone. If a blood clot forms inadequately in the socket or it 
is dislodged, the bone and nerves are exposed, leading to pain. Smoking, excessive 
extraction trauma, difficult disimpactions of third molars, vasoconstrictor in local 
anesthetic, and oral contraceptives are some of the predisposing factors to alveolar 
osteitis. Alveolar osteitis can strike 3–5 days after an extraction and may persist for 
a week. The exposed bone is acutely tender to touch; hence, mechanical stimulation 
by tongue movement and food particles results in frequent acute pain. On clinical 
examination, the socket appears empty with visible bony lamina dura.
Minimization of trauma related to the extraction procedure can be an 
important factor in prevention of dry socket. Since removal of the debris from 
the socket expedites healing, irrigation with warmed saline or chlorhexidine is 
suggestive. Use of intra-alveolar dressing materials such as bismuth iodoform 
paraffin paste and lidocaine gel on ribbon gauze can protect the socket from 
painful stimuli and collection of food debris. These dressing materials also impart 
a soothing sensation of warmth in the painful area. Usually after one or two 
dressings, significant pain relief is achieved. It is better to be on the lookout for 
signs of infection, such as pus in the socket, localized swelling, and lymphade-
nopathy. Antibiotics should be prescribed if these signs are there. It is crucial that 
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the reason for infection is determined such as retained root or bony fragments. A 
radiograph can be helpful. Surgical extraction is indicated for removal of root tip 
or bone sequestrum [6, 13, 23].
3.4 Burning mouth syndrome (BMS)
Burning mouth syndrome (BMS) is a complex painful disorder that is character-
ized by warm, burning, or tingling sensation in the oral mucosa, tongue, or lips. The 
pain may be associated with a feeling of intermittent numbness. Other associated fea-
tures may include metallic taste and dryness in the mouth. Interestingly, a variety of 
names has been associated with this condition such as oral dysesthesia, stomatodynia, 
glossodynia, stomatopyrosis, glossopyrosis, sore mouth, and sore tongue. BMS is a 
reasonably common chronic complaint to affect middle age or elderly patients, espe-
cially females. Diagnosis of BMS is challenging, because usually no clear-cut dental or 
medical cause is evident and laboratory findings does not reveal any abnormality.
BMS can be classified into two clinical variants, namely, primary and secondary 
BMS. If no underlying medical or dental problem becomes evident on investiga-
tions, the diagnosis is primary or idiopathic BMS. Probably, the damage to the 
nerves that control pain and taste leads to primary BMS. Secondary BMS is caused 
by local, systemic, or psychological factors. A few common causes of secondary 
BMS include, dry mouth, acid reflux, deficiency of iron or vitamin B, hormonal dis-
turbances (such as from thyroid problem or diabetes), etc. Because burning mouth 
syndrome can be associated with a wide array of local, systemic, or psychological 
conditions, an ambitious diagnostic approach is warranted. This approach should 
be based on a detailed history, clinical examination, laboratory tests, and exclusion 
of all other possible oral and systemic problems.
If no organic cause can be found and diagnosis suggests psychological factors 
such as anxiety, stress, and depression, it is advisable to make the patient aware 
by explaining that depression and other emotional disturbances are just as much 
illnesses and cause as much suffering as physical diseases. Apart from psychogenic 
medications, cognitive behavioral therapy is indicated in BMS.
Depending on the causative factors, medications used for BMS include antidepres-
sants, analgesics, antiepileptic, antifungal, antibacterial, sialagogues, antihistamines, 
anxiolytics, antipsychotics, and vitamin, mineral, and hormonal replacements.
The topical application of clonazepam (by sucking a tablet of 1 mg), three times 
a day for 14 days can reduce the burning symptoms. Aloe vera gel also helps to 
reduce the burning sensation and pain in the sore areas of the tongue. Symptoms of 
secondary BMS go away when the underlying medical condition, such as diabetes or 
acid reflux, is treated [24, 25].
Overall, successful management of BMS is dependent on a holistic diagnostic 
workup and collaborative management involving dental practitioners, psychologist, 
and physician.
3.5  Specific anticancer treatment painful oral complications: oral  
mucositis (OM)
This grossly painful disorder usually occurs as a complication of chemo- and 
radiotherapy. An allergic reaction to certain medications, dental materials, or infec-
tions may also lead to nonspecific mucositis. Oral mucosal injury is the hallmark of 
OM that occurs due to the interference of chemotherapy and/or radiation therapy 
with normal turnover of oral mucosal cells.
Chemotherapy-induced and/or radiation therapy-induced OM clinically mani-
fests as the painful swelling, atrophy, and ulceration of the oral mucosa. Candida 
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and streptococcal infections may also occur due to the disintegration of the oral 
mucosa.OM-affecting pharynx and other areas of alimentary canal can lead to 
complications, including dysphagia, electrolyte disturbances, systemic infection, 
malnutrition, and even death [20, 26].
Oral mucosal injury tends to be acute in cases where chemotherapy is admin-
istered over a short span of time. Chemotherapy-induced mucosal damage usu-
ally develops within a week after the start of therapy and peaks within 2 weeks. 
Radiotherapy-induced mucositis has a slower onset since it is most often adminis-
tered in small fractions given over weeks. Radiation-induced mucositis typically 
starts in 1–2 weeks of starting the radiotherapy at cumulative doses of about 15 Gy 
(gray, a unit of absorbed radiation). At doses greater than 30 Gy, OM attains full 
severity and may last for weeks or even months.
Factors related to treatment and patient characteristic can influence the devel-
opment of OM. Treatment factors that influence the severity and presence of 
mucositis include the class, dose, and administration frequency of systemic che-
motherapeutic agents, radiation dose and field, and use of adjuvant chemotherapy 
and radiation. The majority of patients treated for head and neck cancers or those 
receiving high-dose chemotherapy develop severe OM. Usually the healing within 
lesions of OM is evidenced within 2–4 weeks after stoppage of either therapy.
So much so, the OM is a painful and agonizing condition that it has a drastic 
impact on oral hygiene maintenance, nutritional intake, and quality of life. Current 
clinical management of OM is largely supportive and aimed at maintaining oral 
hygiene, pain relief, and nutritional support. A majority of patients with mucositis 
pain has difficulty in food intake through mouth and a nasogastric tube or gastros-
tomy tube helps to achieve nutrition. Diet modifications in the form of liquid and 
soft diet are suggested to facilitate the food intake during the cancer therapy [27].
Maintenance of oral hygiene has an important contribution in the prevention 
and management of OM; however, it remains a neglected habit. Moreover, a good 
oral care helps to prevent secondary infection and sepsis in the lesions of OM. Oral 
hygiene measure such as tooth brushing, flossing, rinsing with sterile water, and 
using mouth moisturizers helps control pain and bleeding and prevent infections of 
the oral soft tissue. However, at the same time, caution must be exercised that tooth 
brushing and flossing do not traumatize the oral mucosa. In case, a patient with OM 
is unable to tolerate the use of a tooth brush, oral sponges and foam brushes can be 
used instead.
Simple analgesia, e.g., paracetamol (1 g four times a day) in soluble form used 
as a mouth rinse will be adequate to control the mild-to-moderate pain of OM. For 
controlling severe pain, opioid analgesics (e.g., hydromorphone or morphine) can 
be used. Use of opioids is both logical and appropriate to alleviate the intolerable 
pain of OM, and strong opioids can be helpful in this direction.
When swallowing pills can be problematic in patients with severe OM, the use of 
parenteral administration of opioid analgesics is required. For seeking short-term 
relief in pain of OM, oral rinsing with 2% viscous lidocaine (topical anesthetic) 
in combination with diphenhydramine and magnesium aluminum hydroxide may 
allow the patient to eat and maintain oral hygiene. Mucosal-coating agents such as 
sucralfate, Gelclair®, and Caphosol® by adhering to oral mucosa form a protective 
coating. This coating aids in patient comfort by shielding the exposed and over-
stimulated nerve endings [20].
Prevention of OM is also an important aspect to be considered and has involved 
multiple medications. The updated clinical practice guidelines for the preven-
tion and treatment of mucositis have suggested the use of chemo-preventative 
agents to prevent and/or reduce severity of OM. The most commonly prescribed 
preventative agents for OM are ice chips (given 30 minutes prior to chemotherapy) 
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or amifostine (a thiol drug) and keratinocyte growth factor-1 (palifermin). 
Moreover, the Multinational Association of Supportive Care in Cancer (MASCC) 
and the International Society for Oral Oncology (ISOO) guidelines for treatment 
of oral recommends the use of benzydamine for prevention of radiation-induced 
OM. Benzydamine hydrochloride (HCl) is a cytoprotectant with analgesic, anti-
inflammatory, and antimicrobial activity. On being used as an oral rinse, it signifi-
cantly reduced OM-related erythema and ulceration [20].
3.6 Acute necrotizing ulcerative gingivitis (ANUG)
Acute necrotizing ulcerative gingivitis (ANUG) is an acute infection of the gingiva 
and is characterized by pain, bleeding, fetid breath, and gingival necrosis. Fever, mal-
aise, and regional lymphadenopathy may be accompanying features. Oral functions 
including speaking and swallowing become difficult due to intense gingival pain.
Destructive pattern in the form of gingival ulcerations, necrosis, and ‘punched-
out’ ulcerated papillae makes ANUG unique when compared with other periodontal 
diseases. Initially cratered ulcers affect the tips of interdental papilla, later on 
spreading along gingival margins. ANUG most commonly affects smokers and 
stressful immunocompromised individuals. Other risk factors are neglected oral 
hygiene, sleep deprivation, and malnutrition. ANUG is an opportunistic bacterial 
infection that is caused by a complex of fusiforms and spirochaetes.
Maintenance of oral hygiene through self-care and gentle debridement by the 
dentist is the stepping stone to the successful management of ANUG. Patients 
may be advised to use mouth rinses, such as warm normal saline or 1.5% hydrogen 
peroxide or 0.12% chlorhexidine at hourly intervals for the first few days. Analgesics 
may help to ward off the intense pain associated with ANUG. In order to prevent 
recurrence of ANUG, the patient must be educated to maintain high personal oral 
hygiene, to have adequate nutrition, and to get sufficient rest. Antibiotics are indi-
cated in case of systemic involvement. The recommended antibiotics are amoxicillin 
500 mg, three times daily for 10 days plus metronidazole 250 mg, three times daily 
for 10 days. The healed gingival craters can act as stagnation areas where plaque can 
accumulate and ANUG may reoccur. For correction of superficial craters, gingivec-
tomy and/or gingivoplasty procedures may be helpful. For rehabilitation of deep 
craters, periodontal flap surgery or regenerative surgery may be considered [28–30].
3.7 Desquamative gingivitis (DG)
Desquamative gingivitis (DG) is a specific clinical presentation of unknown 
etiology in which the attached gingiva appears fiery red, glazed, and friable. 
Desquamative gingivitis may be a clinical manifestation of various mucocutaneous 
disorders—erythema multiforme, erosive lichen planus, pemphigus, pemphigoid, 
and psoriasis. DG is characterized by gingival soreness and burning sensation, 
which worsens on eating spicy and acidic food. The typical clinical feature in severe 
cases is of desquamation of gingival epithelium. The treatment of DG is aimed 
at minimizing the gingival injury and irritation. Therefore, the patient should 
avoid spicy or acidic foods. Oral hygiene maintenance can be helpful in removal of 
exacerbating factors, particularly dental plaque. However, in order to avoid injury 
to the friable gingiva, tooth brushing should be done gently with a soft tooth brush 
or toothette. Use of an anesthetic mouthwash, e.g., benzydamine hydrochloride 
can be helpful in tackling the pain. Topical therapies are the mainstay of treatment 
for DG. High potency corticosteroid gels are commonly used as first-line topical 
therapy. Clobetasole-17-propionate or fluocinonide 0.05% in gel form can be pre-
scribed. Ease of gel application can be facilitated via the use of custom fabricated 
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trays. Furthermore, 0.1% triamcinolone orabase can also be used. For complete 
resolution of DG, it is important that the underlying disease leading to DG is 
diagnosed and treated appropriately by specific therapies [31, 32].
4. Conclusion
Odontogenic and nonodontogenic pain may occur due to a variety of factors and 
causes. A differential diagnosis of orofacial pain, distinguishing between odon-
togenic pathologies and nonodontogenic painful etiologies, is a requisite before 
taking any clinical or pharmacological decision for pain management. Exactness 
of differential diagnosis is dependent on a thorough medical and dental history, 
comprehensive clinical examination, and appropriate investigations. Any deci-
sion on pain management should encompass a treatment regimen (e.g. palliative, 
dental, pharmacological, and psychological) that can adequately address the clinical 
problem of pain. For the successful accomplishment of a durable pain manage-
ment, the treatment decisions should be based upon the best-available evidence, 
consideration of cost-effectiveness, and patient’s expectation. Specialist referral is 
warranted, if the conventional clinical and pharmacological measures fail to control 
the odontogenic or non-odontogenic oral pain [1].
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